MTOR and breast cancer: This is a transcription factor highly expressed in BC involved in transcription of genes linked to cell proliferation and drug resistance that is translocated in the nucleus after AKT/mTOR or p90RSK-mediated phosphorylation, suggesting that the results obtained by Li et al., (2018) could be linked to quercetin-mediated inhibition of AKT/mTOR pathway [48].